Table 3 The comparison of clinical outcome of patients with liver cirrhosis.

From: Outcome of liver cirrhosis patients requiring prolonged mechanical ventilation

Variable

Survival cases (n = 41)

Mortality cases (n = 17)

P value

Age (years), mean ± SD

65.5 ± 12.0

64.9 ± 11.3

0.867

Sex, n(%)

   

Male

26(63.4%)

12(70.6%)

0.601

Female

15(36.6%)

5(29.4%)

 

Category of transferred ICU, n(%)

  

1.000

Surgery

9(22.0%)

4(23.5%)

 

Medicine

32(78.0%)

13(76.5%)

 

Hepatitis B virus, n(%)

5(12.2%)

3(17.6)

0.681

Hepatitis C virus, n(%)

10(24.4%)

3(17.6%)

0.736

Alcoholism, n(%)

2(4.9%)

1(5.9%)

1.000

Length of ICU stay, mean ± SD

21.6 ± 10.2

18.8 ± 5.7

0.295

Length of RCC stay, mean ± SD

17.5 ± 11.0

15.1 ± 9.9

0.425

ICU APACHE II scores, mean ± SD

21.3 ± 7.7

23.9 ± 6.6

0.250

RCC APACHE II scores, mean ± SD

18.3 ± 5.8

20.1 ± 5.3

0.281

Hemodialysis, n(%)

  

0.311

None

33(80.5%)

11(64.7%)

 

HD

8(19.5%)

6(35.3%)

 

Diagnosis of RCC admission, n(%)

  

0.242

Lung infection

20(48.8%)

9(52.9%)

 

Decompensated heart disease

2(4.9%)

0(0%)

 

Neuromuscular disease

14(34.1%)

5(29.4%)

 

Infection other than pneumonia

4(9.8%)

0(0%)

 

Decompensated gastrointestinal disease

1(2.4%)

3(17.6%)

 

Laboratory findings, mean ± SD

   

Blood urea nitrogen, mg/dl

45.4 ± 33.6

53.6 ± 22.9

0.359

Creatinine, mg/dl

1.6 ± 1.6

2.6 ± 1.9

0.051

Serum sodium, mEq/L

142.7 ± 6.1

142.1 ± 10.7

0.807

Bilirubin Total, mg/dl

2.4 ± 4.4

3.2 ± 6.0

0.543

Albumin, g/dl

2.7 ± 0.5

2.5 ± 0.6

0.371

Hemoglobin, g/dl

9.9 ± 1.3

9.6 ± 1.4

0.391

Phosphate, mg/dl

3.3 ± 1.5

3.0 ± 1.4

0.517

MELD score, mean ± SD

13.7 ± 6.2

18.9 ± 8.8

0.036

  1. ICU, intensive care unit; RCC, respiratory care center.